© Foto: Monika Skolimowska - dpa-Zentralbild/dpa
© 2023 wallstreetONLINE
© Foto: Monika Skolimowska - dpa-Zentralbild/dpa
Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
Do | AbbVie partners with EvolveImmune for cancer therapy | ||
Do | AbbVie Aktie: Klarer Vorteil im Wettbewerb! | AbbVie, der renommierte US-Pharmakonzern, hat eine bahnbrechende Zusammenarbeit mit EvolveImmune Therapeutics bekanntgegeben. Diese Partnerschaft zielt darauf ab, multispecifische Biologika für die... ► Artikel lesen | |
Do | AbbVie pays $65M, with $1.4B chaser, for options on EvolveImmune's T-cell engagers | ||
Do | AbbVie (NYSE:ABBV) Hits New 12-Month High on Strong Earnings | ||
Do | AbbVie, EvolveImmune To Develop Multispecific Biologics For Multiple Targets In Oncology | WASHINGTON (dpa-AFX) - AbbVie (ABBV) and EvolveImmune Therapeutics announced a collaboration and option-to-license agreement to develop multispecific biologics for multiple targets in oncology.... ► Artikel lesen |
Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
Do | AstraZeneca's Drive for China Dominance in Focus as Chief Probed | ||
Do | AstraZeneca Says China President Is Assisting in Local Probe | ||
Do | AstraZeneca China operating normally amid investigations | ||
Mi | IN BRIEF: AstraZeneca China President Leon Wang under investigation | ||
Mi | AstraZeneca China president under investigation |
Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
Do | Johnson & Johnson (NYSE:JNJ) Stock Price Down 0.2% - Time to Sell? | ||
Do | J&J Seeks FDA Approval for Impella ECP Heart Pump | ||
Do | Johnson & Johnson MedTech CIO says 'see you later' | ||
Do | Johnson & Johnson's Tremfya shows promise in 'special site' plaque psoriasis | ||
Mi | Johnson & Johnson completes pilot enrollment in Omnypulse trial |
Unternehmen / Aktien | Kurs | % |
---|---|---|
ABBVIE INC | 188,68 | +1,73 % |
ASTRAZENECA PLC | 131,30 | -2,23 % |
JOHNSON & JOHNSON | 146,30 | -1,06 % |